Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Implantica AGIPLTF Earnings Yield (Joel Greenblatt) % is 0.00% as of . 20. Among 847 Medical Devices & Instruments companies, Implantica AG ranks worse than 118063.64% on this metric.
Implantica AG's Enterprise Value for the quarter that ended in . 20 was $0.00 Mil.
Implantica AG does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Implantica AG's Earnings Yield (Joel Greenblatt) at this moment.
The historical rank and industry rank for Implantica AG's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
IPLTF's Earnings Yield (Joel Greenblatt) % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.1 * Ranked among companies with meaningful Earnings Yield (Joel Greenblatt) % only.
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Implantica AG's Forward Rate of Return (Yacktman) % for the quarter that ended in . 20 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Implantica AG (OTCPK:IPLTF) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Implantica AG Earnings Yield (Joel Greenblatt) % Related Terms
Implantica AG Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Implantica AG's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Implantica AG Earnings Yield (Joel Greenblatt) % Chart
Implantica AG Annual Data
Trend
Earnings Yield (Joel Greenblatt) %
Implantica AG Semi-Annual Data
Earnings Yield (Joel Greenblatt) %
IPLTF vs : Earnings Yield (Joel Greenblatt) % Comparison
For the Medical Devices subindustry, Implantica AG's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Implantica AG Earnings Yield (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Implantica AG's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Implantica AG's Earnings Yield (Joel Greenblatt) % falls into.
Implantica AG Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Implantica AGs Earnings Yield (Joel Greenblatt) for the fiscal year that ended in . 20 is calculated as
What does a Earnings Yield (Joel Greenblatt) % of 0.00% mean?
Implantica AG (IPLTF) has a Earnings Yield (Joel Greenblatt) % of 0.00% as of . 20. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Implantica AG and its competitors. According to the industry distribution chart, Implantica AG ranks #999999 out of 847 companies in the Medical Devices & Instruments industry.
Is Implantica AG's Earnings Yield (Joel Greenblatt) % too high?
Implantica AG's current Earnings Yield (Joel Greenblatt) % is 0.00%. Based on the distribution chart, Implantica AG ranks #999999 out of 847 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Implantica AG's Earnings Yield (Joel Greenblatt) % compare to ?
According to the Medical Devices & Instruments industry distribution chart, Implantica AG ranks #999999 out of 847 companies for Earnings Yield (Joel Greenblatt) %. This places Implantica AG in the lower half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 1.10. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median Earnings Yield (Joel Greenblatt) % among Medical Devices & Instruments companies is 1.10, based on 847 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Implantica AG and its competitors. For the Medical Devices & Instruments industry, the median Earnings Yield (Joel Greenblatt) % is 1.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Implantica AG's current Earnings Yield (Joel Greenblatt) % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Implantica AG stock overvalued right now?
Implantica AG (IPLTF) has a current Earnings Yield (Joel Greenblatt) % of 0.00%. The current Earnings Yield (Joel Greenblatt) % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For Implantica AG (IPLTF), the current Earnings Yield (Joel Greenblatt) % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Implantica AG is a medtech group providing effective care for serious health conditions and improving patients' quality of life by bringing technology into the body. The therapies Implantica develops are based on implants that are medical devices inserted into the patient's body and are intended to remain in place permanently or semi-permanently, using electrical power provided by a battery. The company has developed a broad, patent-protected product pipeline based partly on its two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body, and communicate with the caregiver at a distance, and a wireless energising platform designed to power remote-controlled implants wirelessly through intact skin.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IPLTF has been successfully added to your 
